Table 1.

Demography of participants

Combined total (n = 289)Training Group (n = 189)Test group (n = 100)
Control (n = 175)Control (n = 102)Control (n = 73)
Healthy (n = 160)90 (88%)70 (96%)
Renal oncocytoma (n = 6)4 (4%)2 (3%)
Benign (n = 9)8 (8%)1 (1%)
SexMaleFemaleAgeMedian
139 (79%)36 (21%)39
Kidney cancer (n = 114)Kidney cancer (n = 87)Kidney cancer (n = 27)
SexMaleFemaleAgeMedian
73 (60%)41 (36%)50.9
Cell typeCell typepT StageCell typepT Stage
Ia/IbIIIIIa/IIIbIVIa/IbIIa/IIbIIIa/IIIbIV
Clear cell RCC (n = 89)66 (75%)3991823 (88%)12191
Papillary RCC (n = 6)6 (7%)3111
Chromophobe RCC (n = 7)6 (7%)4111 (4%)1
TCC (transitional Cell Carcinoma) (n = 9)8 (9%)1 (4%)
Unclassified RCC (n = 3)1 (1%)12 (8%)
Total46 (52%)12 (14%)20 (23%)1 (1%)13 (50%)1 (4%)9 (35%)1 (4%)